Abstract
Background
The current study was conducted to assess long-term outcomes after primary ileocolic resection for Crohn’s disease (CD) and to identify factors associated with surgical relapse in the era of immunosuppressive medications.
Methods
Data were collected retrospectively on 116 consecutive patients, who underwent primary ileocolic resection for CD at a tertiary referral center between 1997 and 2006. Medical records were reviewed, and the use of immunomodulators was noted. The cumulative probability for a second operation due to recurrent CD was described by Kaplan–Meier curves.
Results
Ten patients (8.6 %) developed surgical recurrence after a mean follow-up period of 8.1 (±2.6) years. The percentage of patients not requiring further surgery was 96.5% and 88.0 % at 5 and 10 years, respectively. An urgent indication for surgery was significantly associated with the necessity of repeated intestinal resection (hazard ratio 5.6, 95 % confidence interval 1.2–27.0, p = 0.0145). In addition, postoperative exposure to azathioprine/6-mercaptopurine for more than 3 months decreased the probability of surgical recurrence significantly (hazard ratio 2.5, 95 % confidence interval 0.6–9.9, p = 0.0349).
Conclusions
In contrast to previous studies, we observed a significant low surgical recurrence rate after primary ileocolic resection. Additionally, maintenance treatment with azathioprine/6-mercaptopurine after surgery may reduce the necessity for repeat surgical intervention.
Similar content being viewed by others
References
Bernell O, Lapidus A, Hellers G (2000) Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn’s disease. Br J Surg 87:1697–1701
Freeman HJ (2009) Long-term natural history of Crohn’s disease. World J Gastroenterol 15:1315–1318
Lazarev M, Ullman T, Schraut WH et al (2010) Small bowel resection rates in Crohn’s disease and the indication for surgery over time: experience from a large tertiary care center. Inflamm Bowel Dis 16:830–835
van Overstraeten ADB, Wolthuis A, D’Hoore A (2012) Surgery for Crohn’s disease in the era of biologicals: a reduced need or delayed verdict? World J Gastroenterol 18:3828–3832
Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB (2010) Natural history of Crohn’s disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates. Gut 59:1200–1206
Lakatos PL, Golovics PA, David G et al (2012) Has there been a change in the natural history of Crohn’s disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977–2009. Am J Gastroenterol 107:579–588
Cannom RR, Kaiser AM, Ault GT, Beart RW Jr, Etzioni DA (2009) Inflammatory bowel disease in the United States from 1998 to 2005: has infliximab affected surgical rates? Am Surg 75:976–980
Rutgeerts P, Geboes K, Vantrappen G et al (1990) Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99:956–963
Yamamoto T (2005) Factors affecting recurrence after surgery for Crohn’s disease. World J Gastroenterol 11:3971–3979
Peyrin-Biroulet L, Deltenre P, Ardizzone S et al (2009) Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Am J Gastroenterol 104:2089–2096
Papay P, Reinisch W, Ho E et al (2010) The impact of thiopurines on the risk of surgical recurrence in patients with Crohn’s disease after first intestinal surgery. Am J Gastroenterol 105:1158–1164
Ikeuchi H, Kusunoki M, Yamamura T (2000) Long-term results of stapled and hand-sewn anastomoses in patients with Crohn’s disease. Dig Surg 17(493–496):51946
Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP (2008) The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies. Int J Colorectal Dis 23:1213–1221
Shivananda S, Hordijk ML, Pena AS, Mayberry JF (1989) Crohn’s disease: risk of recurrence and reoperation in a defined population. Gut 30:990–995
Simillis C, Yamamoto T, Reese GE et al (2008) A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am J Gastroenterol 103:196–205
Unkart JT, Anderson L, Li E et al (2008) Risk factors for surgical recurrence after ileocolic resection of Crohn’s disease. Dis Colon Rectum 51:1211–1216
Yamamoto T, Keighley MR (1999) Stapled functional end-to-end anastomosis in Crohn’s disease. Surg Today 29:679–681
Riss S, Schuster I, Papay P, Mittlbock M, Stift A (2013) Repeat intestinal resections increase the risk of recurrence of Crohn’s disease. Dis Colon Rectum 56:881–887
Riss S, Bittermann C, Zandl S et al (2010) Short-term complications of wide-lumen stapled anastomosis after ileocolic resection for Crohn’s disease: who is at risk? Colorectal Dis 12:e298–e303
Ardizzone S, Maconi G, Sampietro GM et al (2004) Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. Gastroenterology 127:730–740
Sandborn WJ, Hanauer SB, Rutgeerts P et al (2007) Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial. Gut 56:1232–1239
Rutgeerts P, Diamond RH, Bala M et al (2006) Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn’s disease. Gastrointest Endosc 63:433–442
Feagan BG, Panaccione R, Sandborn WJ et al (2008) Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn’s disease: results from the CHARM study. Gastroenterology 135:1493–1499
Lock MR, Farmer RG, Fazio VW et al (1981) Recurrence and reoperation for Crohn’s disease: the role of disease location in prognosis. N Engl J Med 304:1586–1588
Borley NR, Mortensen NJ, Chaudry MA et al (2002) Recurrence after abdominal surgery for Crohn’s disease: relationship to disease site and surgical procedure. Dis Colon Rectum 45:377–383
Scarpa M, Angriman I, Barollo M et al (2004) Role of stapled and hand-sewn anastomoses in recurrence of Crohn’s disease. Hepatogastroenterology 51:1053–1057
Greenstein AJ, Lachman P, Sachar DB et al (1988) Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut 29:588–592
Yamamoto T, Allan RN, Keighley MR (1999) Perforating ileocecal Crohn’s disease does not carry a high risk of recurrence but usually re-presents as perforating disease. Dis Colon Rectum 42:519–524
Gao X, Yang RP, Chen MH et al (2012) Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn’s disease. Scand J Gastroenterol 47:1181–1191
Riss S, Schwameis K, Mittlbock M et al (2013) Sexual function and quality of life after surgical treatment for anal fistulas in Crohn’s disease. Tech Coloproctol 17:89–94
Yamamoto T (2013) Risk factors for symptomatic recurrence after intestinal resection for Crohn’s disease: a retrospective study in a Chinese population. J Gastrointest Surg 17:1540–1541
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riss, S., Schuster, I., Papay, P. et al. Surgical recurrence after primary ileocolic resection for Crohn’s disease. Tech Coloproctol 18, 365–371 (2014). https://doi.org/10.1007/s10151-013-1061-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-013-1061-4